Mechanisms of RhoGDI2 Mediated Lung Cancer Epithelial-Mesenchymal Transition Suppression | Zendy

Huiyan Niu | Zendy; Baogang Wu | Zendy; Hongfang Jiang | Zendy; Hui Li | Zendy; Yi Zhang | Zendy; Peng Yang | Zendy; Ping He | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Mechanisms of RhoGDI2 Mediated Lung Cancer Epithelial-Mesenchymal Transition Suppression

Author(s) -

Huiyan Niu,

Baogang Wu,

Hongfang Jiang,

Hui Li,

Yi Zhang,

Peng Yang,

Ping He

Publication year - 2014

Publication title -

cellular physiology and biochemistry

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.486

H-Index - 87

eISSN - 1421-9778

pISSN - 1015-8987

DOI - 10.1159/000366396

Subject(s) - epithelial–mesenchymal transition , rac1 , a549 cell , slug , vimentin , immunostaining , biology , cancer research , metastasis , microbiology and biotechnology , lung cancer , cell migration , pathology , cell , cancer , immunology , medicine , immunohistochemistry , signal transduction , genetics

The aim of this study was to evaluate the function of RhoGDI2 in lung cancer epithelial-mesenchymal transition (EMT) process and to illustrate the underlying mechanisms that will lead to improvement of lung cancer treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research